MAGEA3 and melanoma: Our results do show significant associations of MAGE-A3 and TPTE expression with melanoma-related events in young adult and adult melanoma patients, supporting existing evidence for MAGE-A3’s prognostic value and introducing TPTE as a possible prognostic indicator [31, 32], highlighting the need for these and other TAAs to be investigated in larger study populations.